I802F (p.Ile802Phe) variant of PIEZO2 (Q9H5I5)
I802F (p.Ile802Phe) in PIEZO2 (Q9H5I5) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as pathogenic in the context of Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome. The available variant effect predictions contribute to a CATVariant prioritization score of 0.60 / 1. The record also includes published literature and structural context.
I802F (p.Ile802Phe) variant details
- p.Ile802Phe
- rs587777076
- ClinGen CA149687
- ClinVar RCV000082866
- UniProt VAR 070938
- Pathogenic
- Arthrogryposis- oculomotor limitation-electroretinal anomalies syndrome
- Missense
- Variant Prioritization Score for Impact Estimate 0.596
- REVEL 0.61
- ESM-1b 1.00
- AlphaMissense 0.95
- MetaLR 0.14
- MetaSVM -0.86
- CADD 26.50
- ClinVar: Pathogenic (Arthrogryposis- oculomotor limitation-electroretinal anomalies s)
- EBI: Pathogenic (in DA5)
- UniProt: Pathogenic (in DA5)
- Structural context available
- Cited in: Gain-of-function mutations in the mechanically activated ion channel PIEZO2 cause a subtype of Distal Arthrogryposis. (PMID 23487782)
- Cited in: Mutations in PIEZO2 cause Gordon syndrome, Marden-Walker syndrome, and distal arthrogryposis type 5. (PMID 24726473)